Skip to content

Genetic Analysis for Fusion Gene Arrangements in Blood (Next-Generation Sequencing)

Published: August 9, 2026Updated: August 16, 2026

This test checks for specific genetic rearrangements—fusions—between genes in your blood cells that may be linked to certain cancers or blood disorders.

Quick summary

["Helps identify genetic changes that could influence cancer treatment options or monitor disease progression."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
101383-8
Short code
FUS gene rearrangements Bld/T FISH
Synonyms
FUS gene rearrangements Bld/T FISH
Category
chemistry
Sample
whole-blood
Container
Lavender-top (EDTA)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
fish
Specimen volume
3 mL
Stability
Room temperature: 4h, Refrigerated: 24h
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your doctor may recommend this test if you have a suspected blood cancer (e.g., leukemia, lymphoma) or other conditions where fusion genes are known to play a role, such as certain types of solid tumors. It may also be used to guide personalized treatment plans.

How the Test Works

A small blood sample is collected and analyzed using advanced sequencing technology to detect abnormal gene fusions. This process identifies specific DNA sequences that have been rearranged, often involving genes like *BCR-ABL* or *EML4-ALK*, which are common in certain cancers.

Sample Collection and Preparation

Whole blood is drawn from a vein, typically in the arm. The sample is processed and sent to a lab for genetic sequencing. Results are usually available within 1–2 weeks, depending on lab workflows.

What the Results Mean

Positive results indicate the presence of a known fusion gene, which may confirm a diagnosis or help tailor treatment (e.g., targeted therapies like tyrosine kinase inhibitors). Negative results mean no detectable fusion was found in this sample.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

Fusion Gene Testing (NGS)

Frequently asked questions

Genetic fusion genes are often associated with aggressive cancers or resistance to standard treatments. Identifying them allows doctors to choose more precise therapies, such as drugs that target specific gene mutations.
This test is not a routine screening for healthy individuals but is critical in the diagnosis and management of suspected cancer or blood disorders.
How long will I need to wait for results?
Results typically take 1–2 weeks, but delays may occur depending on lab capacity or additional confirmatory testing. Your doctor will contact you once results are ready.
What if my test comes back positive for a fusion gene?
A positive result means your cancer may respond differently to treatment than others. Your healthcare team will discuss next steps, including possible targeted therapies or clinical trials tailored to your genetic profile.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy